Literature DB >> 6980007

Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.

H Repo, M Leirisalo, A Tiilikainen, O Laitinen.   

Abstract

Chemotactic and chemokinetic migration of polymorphonuclear leukocytes in sera from patients with previous yersinia arthritis and from healthy subjects with or without HLA--B27 were studied by the leading front method. Irrespective of yersinia arthritis, zymosan-activated sera from subjects who were HLA--B27 positive were significantly more chemokinetic than were HLA--B27 negative zymosan-activated sera from healthy control subjects. The chemotactic activities of zymosan-activated sera that were HLA--B27 positive or negative, as determined by chemotactic increments, were much the same. The results suggest that zymosan-activated serum that is HLA--B27 positive stimulates random migration of polymorphonuclear leukocytes, but not their directional migration, more than does HLA--B27 negative serum that has been zymosan activated. This may contribute to accumulation of polymorphonuclear leukocytes at the site of inflammation in vivo and thereby to inflammatory symptoms in yersinia arthritis patients with HLA--B27.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980007     DOI: 10.1002/art.1780250608

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Phagocyte function in juvenile periodontitis.

Authors:  H Repo; L Saxén; M Jäättelä; M Ristola; M Leirisalo-Repo
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Polymorphonuclear leukocyte chemiluminescence response in HLA-B27 positive and negative arthritic patients.

Authors:  R Tertti
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

4.  Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.

Authors:  C T Pease; M Fennell; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

5.  Complement activation and HLA-B27.

Authors:  S Meri; J Partanen; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

6.  Aberrant phagocyte function in Shwachman syndrome.

Authors:  H Repo; E Savilahti; M Leirisalo-Repo
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

7.  Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.

Authors:  P Koivuranta-Vaara; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

8.  Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.

Authors:  H Repo; P Koivuranta-Vaara; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

9.  Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

Authors:  H Repo; M Jäättelä; M Leirisalo-Repo; M Hurme
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  Enhanced neutrophil migration in vivo HLA B27 positive subjects.

Authors:  P Koivuranta-Vaara; H Repo; M Leirisalo; U Kiistala; T Osterman; H Vapaatalo
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.